|Company name||CVS Health Corporation|
|Class period||May 21, 2015 – February 20, 2019|
|Court||Southern District of New York|
NEW YORK, March 15, 2019 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired CVS Health Corporation (NYSE: CVS) securities between May 21, 2015 and February 20, 2019 (the “Class Period”). Investors have until April 26, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
According to the Complaint, the Company made false and misleading statements to the market. A combination of increasing costs and disappointing results from the acquisition of Omnicare, Inc. caused CVS’s expected earnings and financial condition to deteriorate. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CVS, investors suffered damages.
If you purchased CVS securities during the Class Period or continue to hold shares purchased before the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.